Drug Profile
Fenretinide intravenous - SciTech Development
Alternative Names: fenretinide + lipids; nanoFenretinide drug delivery - SciTech Development; nanoFenretinide™; ST-001; ST-001 nanoFenretinideLatest Information Update: 08 Dec 2023
Price :
$50
*
At a glance
- Originator SciTech Development
- Class Antineoplastics; Antivirals; Chemopreventatives; Retinoids; Small molecules
- Mechanism of Action Apoptosis stimulants; Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase I T-cell lymphoma
- Preclinical Viral infections